NATCO PHARMA LIMITED (INDIA)
Imatinib-veenat
“Imatinib” is the Drug / Molecule content in "Veenat". Imatinib belongs to a class of medications known as protein-tyrosine kinase inhibitor.It works by stopping or slowing the growth of cancer cells (tumours).Imatinib stops the addition of phosphate group in signal cascade for cancer cells. Hence works as a form of targeted therapy—only cancer cells are killed through the drug's action.
Indication
Imatinib is used to treat certain types of leukemia (blood cancer), bone marrow disorders, and skin cancer, or certain tumors of the stomach and digestive system.
Note
SCHEDULE H PRESCRIPTION DRUG - CAUTION
To be sold by retail on the prescription of an Oncologist only
Precaution
- Veenat is a prescription drug and should be used under proper medical guidance and advice.
- Cytopenias (reduction or lack of certain cell elements in blood circulation) might occur.
- Severe congestive heart failure and hepatotoxicity may occur.
- Upset stomach, nausea, vomiting, diarrhea, headache, joint pain, muscle cramps/pain, dizziness, blurred vision, or drowsiness may occur.
Strength
100 mg & 400 mg
Packing
1 X 10 Capsules (Strip) & 1 X 120 Capsules (Bottle) - 100 mg 1 X 10 Tablets (Strip) & 1 X 30 Tablets (Bottle) - 400 mg
Storage
Store between 15 C and 30 C , protect from light and moisture.
Was this page helpful?
Imatinib-veenat also available as
NOVARTIS
Glivec-veenat
GLIVEC contains Drug / Molecule called “Imatinib”. It belongs to a class of medications known as protein-tyrosine kinase inhibitor. For survival, cells need signaling through proteins (signal cascade). Here, the phosphate group is added by tyrosine kinase enzyme, which is used by proteins for signal cascade. Imatinib stops the addition of phosphate group in signal cascade for cancer cells. Hence works as a form of targeted therapy—only cancer cells are killed through the drug's action.
“Veenat” is the generic version of Glivec and both contains same drug “Imatinib”.